EGFR Mutations in Lung Adenocarcinomas

This publication has 26 references indexed in Scilit:

• Validation of chromogenic in situ hybridization for detection of EGFR copy number amplification in nonsmall cell lung carcinoma
  Laboratory Investigation, 2007
• Epidermal Growth Factor Receptor Mutation Testing in Lung Cancer: Searching for the Ideal Method
  Clinical Cancer Research, 2007
• Molecular Predictors of Response to Epidermal Growth Factor Receptor Antagonists in Non–Small-Cell Lung Cancer
  Journal of Clinical Oncology, 2007
• Sensitive mutation detection in heterogeneous cancer specimens by massively parallel picoliter reactor sequencing
  Nature Medicine, 2006
• EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations
  Laboratory Investigation, 2005
• Epidermal Growth Factor Receptor Gene and Protein and Gefitinib Sensitivity in Non–Small-Cell Lung Cancer
  JNCI Journal of the National Cancer Institute, 2005
• KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib
  PLoS Medicine, 2005
• EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
  Proceedings of the National Academy of Sciences, 2004
• EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
  Science, 2004
• Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
  New England Journal of Medicine, 2004